FDA Inspection Readiness

FDA Inspection Intelligence
Built by Former FDA Investigators

Former FDA investigators helping pharmaceutical, biotechnology, medical device, food, and cosmetics companies prepare for inspections, respond to FDA observations, and strengthen GMP compliance.

Get Inspection Ready Read the GMP Readiness Guide

Step inside a regulated facility

Industry Universe

Step Inside Every FDA-Regulated Environment

Explore cinematic walkthroughs of the facilities FDA investigators inspect. Each environment surfaces real risks, common 483 observations, and what investigators look for.

Pharmaceutical Manufacturing From dispensing to packaging — every cGMP control under one roof. Enter Environment Biologics Manufacturing Upstream, downstream, and aseptic fill — the biologics pressure points. Enter Environment Medical Device Manufacturing Design controls, CAPA, and complaint handling under 21 CFR 820 / QMSR. Enter Environment Food Manufacturing FSMA, allergen control, and environmental pathogen monitoring. Enter Environment Cosmetics Manufacturing MoCRA compliance — adverse event reporting and facility registration. Enter Environment Compounding Pharmacy USP <797>, <800>, and FDA 503B outsourcing facility expectations. Enter Environment QC Analytical Laboratory HPLC, dissolution, stability, LIMS — and the data integrity that ties them together. Enter Environment Microbiology Laboratory Sterility, endotoxin, EM — the sharp end of contamination control. Enter Environment

Former FDA Investigators   —   Mock FDA Inspection Experts   —   FDA 483 Response Specialists

Former FDA investigators consulting with a client team

Why Choose Us

Former FDA
Expertise

FDAInspections.com is powered by Global Regulatory Partners and led by former FDA investigators with decades of direct agency experience helping regulated companies achieve inspection readiness.

  • Mock FDA Inspections
  • GMP Gap Analysis
  • FDA 483 Response Strategy
  • Warning Letter Remediation
Schedule Virtual Consulting

Core Services

FDA Inspection
Consulting Services

Comprehensive regulatory consulting from investigators who’ve been on both sides of the FDA inspection process.

01

Mock FDA Inspections

Realistic mock inspections conducted by former FDA investigators to identify vulnerabilities before the agency arrives.

Learn More
02

GMP Gap Analysis

Systematic evaluation of your quality systems against current FDA expectations and cGMP requirements.

Learn More
03

FDA 483 Response Support

Strategic response development to address inspectional observations and prevent escalation to warning letters.

Learn More
04

Warning Letter Response

Expert remediation planning and corrective action implementation to resolve FDA enforcement actions.

Learn More

Core Services

FDA Regulatory
Intelligence

Access curated FDA enforcement data and trend analysis to stay ahead of regulatory developments.

FDA Warning Letter Analysis

Searchable intelligence on FDA warning letters across industries, with trend analysis and compliance insights to benchmark your regulatory posture.

Explore Data

FDA 483 Observation Intelligence

Detailed analysis of FDA 483 observations by category, helping companies anticipate inspection focus areas and prepare targeted responses.

Explore Data

FDA Observations &
Actions

Are the Result of Your Quality System.

learn

Training, Webinars, and Inspection Resources

Take Action

Prepare Before
FDA Arrives

Don’t wait for a Form 483 or warning letter to take action. Our team of former FDA investigators will assess your readiness and build a tailored compliance strategy.

Schedule Virtual Consulting Contact

Common Questions

Frequently Asked Questions

FDA inspection readiness is the state of preparedness a regulated company maintains to successfully undergo an FDA inspection at any time. It includes compliant quality systems, trained staff, complete documentation, and effective CAPA processes aligned with cGMP requirements.

An FDA Form 483 lists inspectional observations of conditions that may violate the Food, Drug, and Cosmetic Act. Companies should respond within 15 business days with specific corrective actions. Failure to address observations can escalate to warning letters or consent decrees.

Companies can prepare by conducting mock FDA inspections with former investigators, performing GMP gap analyses, ensuring documentation completeness, training staff on inspection protocols, and establishing robust deviation and CAPA management systems.

Yes. Mock inspections conducted by experienced former FDA investigators identify compliance gaps before the agency arrives, allowing companies to remediate weaknesses and build confidence in their quality systems.

Once your dates are confirmed, we provide secure payment options including card and online transfer. A deposit secures your booking, with the balance due closer to arrival. Full details are shared clearly before any payment is made.

Warning Letters 483 Observations